PTH and hypercalcemia disease: In the complex context of SLE, hypercalcemia may arise from diverse mechanisms, including antibodies against parathyroid hormone-related peptides or stimulating receptors, heightened osteoclast activity leading to bone resorption, and pro-inflammatory cytokine disruption of bone turnover during active SLE phases (10).